Need Help?
Copied to clipboard!

Validating ctDNA Observation vs. Routine Investigations (VICTORI) Study

VICTORI is an observational, prospective study exploring the use of the NeXT Personal ctDNA assay in exploring minimal residual disease (MRD) in patients with colorectal cancer following curative intent surgery. Whole-genome informed panels of ~1,800 variants were created for patients, and were used to interrogate plasma samples collected at baseline, and weeks 2, 4, 6 and 8 post-surgery as well as every 3 months on surveillance.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD50000002987 Illumina NovaSeq 6000 218